-+ 0.00%
-+ 0.00%
-+ 0.00%

Simcere Pharmaceutical Group Ltd. and Connect Biopharma Secure NDA Acceptance for Rademikibart by China's National Medical Products Administration

Reuters·07/08/2025 04:22:46

Please log in to view news